University of Alabama Wins $16 Million Grant to Develop Possible HIV Vaccine
August 12, 2003
The National Institute of Allergy and Infectious Diseases has awarded a $16 million grant to the University of Alabama-Birmingham to fund HIV vaccine development efforts. In a news release yesterday, UAB announced it has been chosen to lead the 4.5-year study, which will also be conducted at Harvard and Emory universities and at Novavax Inc. The team will develop and test a vaccine in animals, then conduct a small-scale study of the vaccine in humans. UAB professor of microbiology and medicine Dr. Jiri Mestecky will lead the study.Adapted from:
Merck Senior Vice President of Vaccine Research Leaving to Join International AIDS Vaccine Initiative
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.